William Blair Starts McKesson (MCK) at Outperform, Sees Durable Competitive Moat

William Blair initiated coverage of McKesson Corporation (NYSE: MCK) with an Outperform rating, citing its “durable competitive moat” and growth potential driven by specialty medicines and demographic trends. This follows McKesson’s strategic move to divest a minority stake in its medical-surgical solutions business to Apollo Global Management for $1.25 billion, aiming to ultimately spin off the unit to focus on its core pharmaceutical distribution. The analyst views this as a crucial step in streamlining operations and reducing uncertainty around the medical-surgical unit’s valuation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin